title: Fc-engineered EGF-R antibodies mediate improved antibody-dependent cellular cytotoxicity (ADCC) against KRAS-mutated tumor cells.
authors.affiliation: Section for Stem Cell Transplantation and Immunotherapy, Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
authors.forename: Martin
authors.initials: M
authors.lastname: Schlaeth
authors.forename: Sven
authors.initials: S
authors.lastname: Berger
authors.forename: Stefanie
authors.initials: S
authors.lastname: Derer
authors.forename: Katja
authors.initials: K
authors.lastname: Klausz
authors.forename: Stefan
authors.initials: S
authors.lastname: Lohse
authors.forename: Michael
authors.initials: M
authors.lastname: Dechant
authors.forename: Greg A
authors.initials: GA
authors.lastname: Lazar
authors.forename: Tanja
authors.initials: T
authors.lastname: Schneider-Merck
authors.forename: Matthias
authors.initials: M
authors.lastname: Peipp
authors.forename: Thomas
authors.initials: T
authors.lastname: Valerius